Prediction of Cranial Radiotherapy Treatment in Pediatric Acute Lymphoblastic Leukemia Patients Using Machine Learning: A Case Study at MAHAK Hospital
Authors:
Open Access
- 1 November 2020
- journal article
- research article
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Prevention
- Vol. 21 (11) , 3211-3219
Abstract
Background: Acute Lymphoblastic Leukemia (ALL) is the most common blood disease in children and is responsible for the most deaths amongst children. Due to major improvements in the treatment protocols in the 50-years period, the survivability of this disease has witnessed dramatic rise until this date which is about 90 percent. There are many investigations tending to indicate the efficiency of cranial radiotherapy found out that without that, outcome of the patients did not change and even it improved at some cases. Methods: the main aim of this study is predicting cranial radiotherapy treatment in pediatric acute lymphoblastic leukemia patients using machine learning. Scope of this paper is intertwined with predicting the necessity of one of the treatment modalities that has been used for many years for this group of patients named Cranial Radiotherapy (CRT). For this purpose, a case study is considered at Mahak charity hospital. In this paper, our focus is on ALL patients aged 0 to 17 treated at Mahak hospital, one of the best centers for treatment of childhood malignancies in Iran. Dataset analyzed in this study is gathered by the research team from patient’s paper-based files. Our dataset consists of 241 observations on patients with 31 attributes after the data cleaning process. Our designed machine learning model for predicting cranial radiotherapy treatment in pediatric acute lymphoblastic leukemia patients is a stacked ensemble classifier of independently strong models with a meta-learner to tune the weights and parameters of the base classifiers. Results: The stacked ensemble classifier show highly reasonable performance with AUC of 87.52%. Moreover, the attributes are ranked based on their predictive power and the most important variable for CRT necessity prediction is the disease relapse. Conclusion: In order to conclude, derived from previous studies regarding CRT it is not only cost-effective but also more healthy to eradicate the use of CRT for the treatment of childhood ALL. Furthermore, it is valuable to increase the clinical databases by creating more synthetic health databases not only for research purposes but also for physicians to keep track of their patient’s status.Keywords
This publication has 13 references indexed in Scilit:
- A review of the automated detection and classification of acute leukaemia: Coherent taxonomy, datasets, validation and performance measurements, motivation, open challenges and recommendationsComputer Methods and Programs in Biomedicine, 2018
- Survival improvement by decade of patients aged 0–14 years with acute lymphoblastic leukemia: a SEER analysisScientific Reports, 2014
- Validation of the Total Dysphagia Risk Score (TDRS) as a predictive measure for acute swallowing dysfunction induced by chemoradiotherapy for head and neck cancersRadiotherapy and Oncology, 2010
- Predicting the efficacy of radiotherapy in individual glioblastoma patientsin vivo:a mathematical modeling approachPhysics in Medicine & Biology, 2010
- Datamining approaches for modeling tumor control probabilityActa Oncologica, 2010
- Treating Childhood Acute Lymphoblastic Leukemia without Cranial IrradiationNew England Journal of Medicine, 2009
- Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Adaptive prediction of respiratory motion for motion compensation radiotherapyPhysics in Medicine & Biology, 2007
- Risk Factors for Acute Leukemia in Children: A ReviewEnvironmental Health Perspectives, 2007
- Use of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostateRadiotherapy and Oncology, 2004